Texcell attending ISBiotech 5th Annual Spring Meeting

Texcell will be attending the 5th Annual ISBiotech Spring Meeting located in Washington D.C. this coming Spring.  The areas that will be discussed during this meeting will include products such as vaccines for numerous strains of flu and other potential pandemic viruses, dendritic cellular cancer vaccines, activated T cells, VLP vaccines and AAV viral vectors made with baculovirus, plus three-dimensional structures that can replace failed tissue.